Test Center

My Recent Searches

  • No Recent Search.

My Tests Viewed

  • No Test Viewed.
Test Name

BRCAvantage®, Comprehensive

CPT Code(s)

81162

Physician Attestation of Informed Consent

This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.

Clinical Significance

This test detects mutations in the BRCA1 and BRCA2 genes which are the most common causes of hereditary breast and ovarian cancers.

Includes

BRCA1 Sequencing, BRCA1 Deletion/Duplication, BRCA2 Sequencing, BRCA2 Deletion/Duplication, Comprehensive Interpretation

Methodology

Next Generation Sequencing with Microarray confirmation

Reference Range(s)

See Laboratory Report

Test FAQ

BRCAvantage(TM), Comprehensive

Alternative Name(s)

BRACA

To view specimen requirements and codes please Select a regional laboratory.

Not sure which laboratory serves your office? Call us 866-MYQUEST (866-697-8378)

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.

91863
91863
91863
91863
91863
91863X
91863
91863
91863
91863
91863X
91863
91863
91863
91863
91863
91863
91863
91863X
91863
91863
BRCAvantage®, Comprehensive
91863